Abstract
Alzheimer's Disease is a progressive neurodegenerative condition that results in cognitive decline and behavioral changes. This article aims to analyze the therapeutic potential of phytocannabinoids in Alzheimer's Disease. We conducted a systematic search of articles published from 2014 to May 2024 in the MEDLINE (PubMed), LILACS, and SCOPUS databases, using terms related to Alzheimer's Disease, neuroinflammation, endocannabinoid system, phytocannabinoids, cannabis, cannabinoid, cannabidiol, and delta-9-tetrahydrocannabinol. The results of this systematic review provide a comprehensive overview of the interaction between neurodegeneration and the endocannabinoid system, highlighting the potential of phytocannabinoids as therapeutic interventions for Alzheimer's Disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
